Holen Sie sich die Stockscreener-App
9.92
0.40%
-0.04
Schlusskurs vom Vortag:
$9.96
Offen:
$9.94
24-Stunden-Volumen:
86,358
Relative Volume:
1.68
Marktkapitalisierung:
$310.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.10%
1M Leistung:
-0.20%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.92
$9.9501
1-Wochen-Bereich:
$9.90
$9.96
52-Wochen-Spanne:
$9.86
$10.07
Viking Acquisition Corp I Stock (VACI) Company Profile
Firmenname
Viking Acquisition Corp I
Sektor
Branche
Telefon
(631) 353-2402
Adresse
900 THIRD AVENUE, 10TH FLOOR, NEW YORK
Compare VACI vs LION, XXI, UMAC, DMII, BCSS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VACI
Viking Acquisition Corp I
|
9.92 | 310.76M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
9.72 | 2.86B | 2.80B | -224.60M | -1.10M | -0.8751 |
|
XXI
Twenty One Capital Inc
|
6.85 | 2.33B | 0 | 4.35M | 456.40K | 0.3397 |
|
UMAC
Unusual Machines Inc
|
20.76 | 844.13M | 0 | -5.28M | -3.11M | -0.6947 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.94 | 652.45M | 0 | 0 | 0 | -0.0028 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.14 | 592.18M | 0 | 0 | 0 | 0.00 |
Viking Acquisition Corp I Aktie (VACI) Neueste Nachrichten
Viking Acquisition Corp. I Stock Forecast Summary - Meyka
VACI Should I Buy - Intellectia AI
RNGT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
M&G PLC Purchases Shares of 197,365 Viking Holdings Ltd. $VIK - MarketBeat
Viking M&A Expands Into Philadelphia, Targeting Surging Mid-Market Demand - MyChesCo
‘High-grade’ tungsten validates Viking’s Linka acquisition - Mining.com.au
Viking M&A Expands into Philadelphia - citybiz
Acquisition Buzz and Clinical Progress Fuel Viking Therapeutics Momentum - AD HOC NEWS
Viking Therapeutics Gains Momentum Amid Acquisition Chatter - AD HOC NEWS
Acquisition Speculation Fuels Momentum for Viking Therapeutics Stock - AD HOC NEWS
Viking Therapeutics: M&A Buzz and Clinical Progress Fuel Biotech Speculation - AD HOC NEWS
Viking Therapeutics Stock (VKTX) Opinions on VK2735 Obesity Drug Results - Quiver Quantitative
Viking Therapeutics Stock Surges on Clinical Success and Acquisition Buzz - AD HOC NEWS
Readers rank Viking best for river cruises, ocean cruises, dining and more - Stock Titan
Viking’s Linka acquisition shows tungsten results - Mining.com.au
How Viking Holdings Ltd Ordinary Shares stock performs during market turbulenceJuly 2025 Intraday Action & Expert Approved Momentum Ideas - Улправда
Viking Mines enters into US tungsten ground - Mining.com.au
Long term debt to total equity ratio of Viking Acquisition Corp. I Warrant -on Viking Acqn – NYSE:VACI/W - TradingView — Track All Markets
American Tungsten Announces Strategic Investment in Viking Mines - InvestorNews
Viking Mines (ASX:VKA) Acquires Nevada Tungsten Portfolio in Strategic US Expansion - Kalkine Media
Viking Acquisition Corp I SEC 10-Q Report - TradingView — Track All Markets
VACI-UN SEC Filings - Stock Titan
Viking Acquisition Corp. I Reports Earnings Results for the Two Months Ended September 30, 2025 - marketscreener.com
Viking Therapeutics Shares Maintain Upward Momentum on Clinical and Strategic Catalysts - AD HOC NEWS
Viking Therapeutics Stock Surges on Regulatory and Acquisition Catalysts - AD HOC NEWS
Viking Recognized in Cruise Critic’s 2025 Best in Cruise Awards - Yahoo Finance
Viking Therapeutics Stock Surges on Clinical Momentum and Acquisition Buzz - Ad-hoc-news.de
Viking Therapeutics Emerges as a Prime Acquisition Candidate Amid Obesity Drug Advancements - AD HOC NEWS
Asset turnover of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Viking Therapeutics Emerges as a Prime Acquisition Target Following Trial Success - AD HOC NEWS
Viking Acquisition Corp. I Warrant -on Viking Acqn Revenue Breakdown – NYSE:VACI/W - TradingView
Jefferies Projects Strong 2026 Performance for Viking Holdings’ Ocean, River Segments; Capital Strategy Favors Growth ROI - Yahoo Finance
350,000 Units of Viking Acquisition Corp. I are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Viking Therapeutics Faces Renewed Pressure as Pfizer Enters Obesity Drug Race - AD HOC NEWS
Total liabilities & shareholders' equities of Viking Acquisition Corp. I Warrant -on Viking Acqn – BOATS:VACI/W - TradingView
Inventory turnover of Viking Acquisition Corp. I Warrant -on Viking Acqn – BOATS:VACI/W - TradingView
NYSE Content Advisory: Pre-Market update + BLS Reveals First Look at Labor Market Since September - Sahm
Basic earnings per share (basic EPS) of Viking Acquisition Corp. I Warrant -on Viking Acqn – NYSE:VACI/W - TradingView
Diluted net income available to common stockholders of Viking Acquisition Corp. I – BOATS:VACI - TradingView
Check out Viking Acquisition Corp I's stock price (VACI) in real time - CNBC
Diluted net income available to common stockholders of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Viking Acquisition Corp. I (VACI) - Zacks Investment Research
Viking Acquisition Corp. I Income Statement – NYSE:VACI - TradingView
VACI Price History for Viking Acquisition Corp. I Cl A Stock - Barchart.com
Viking Acquisition Corp. I (VACI-UN) Company Profile & Facts - Yahoo! Finance Canada
VACI: Static price chart | Viking Acquisition Corp. I | KYG9582G1047 - MarketScreener
Enterprise value to EBITDA ratio of Viking Acquisition Corp. I Warrant -on Viking Acqn – NYSE:VACI/W - TradingView
Operating margin % of Viking Acquisition Corp. I Warrant -on Viking Acqn – BOATS:VACI/W - TradingView
Basic earnings per share (basic EPS) of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Total revenue of Viking Acquisition Corp. I – NYSE:VACI - TradingView
EBITDA of Viking Acquisition Corp. I – NYSE:VACI - TradingView
Finanzdaten der Viking Acquisition Corp I-Aktie (VACI)
Es liegen keine Finanzdaten für Viking Acquisition Corp I (VACI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):